182 related articles for article (PubMed ID: 10980996)
61. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.
Tong JL; Ran ZH; Shen J; Xiao SD
J Clin Pharm Ther; 2009 Feb; 34(1):41-53. PubMed ID: 19125902
[TBL] [Abstract][Full Text] [Related]
62. Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection.
Cammarota G; Cannizzaro O; Ojetti V; Cianci R; Pastorelli A; Armuzzi A; Gentiloni N; Gasbarrini A; Pirozzi G; Gasbarrini G
Aliment Pharmacol Ther; 2000 Jan; 14(1):73-7. PubMed ID: 10632648
[TBL] [Abstract][Full Text] [Related]
63. Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection.
Kolkman JJ; Tan TG; Oudkerk Pool M; Van Kleef WA; Geraedts AA; Timmerman RJ; Crobach LF; Nicolai JJ; Wolff AA; Van Der Laan J
Aliment Pharmacol Ther; 1997 Dec; 11(6):1123-9. PubMed ID: 9663840
[TBL] [Abstract][Full Text] [Related]
64. Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication.
Spadaccini A; De Fanis C; Sciampa G; Russo L; Silla M; Pantaleone U; Di Virgilio M; Pizzicanella G
Aliment Pharmacol Ther; 1998 Oct; 12(10):997-1001. PubMed ID: 9798805
[TBL] [Abstract][Full Text] [Related]
65. One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin.
Cammarota G; Cannizzaro O; Tursi A; Papa A; Gasbarrini A; Cuoco L; Cianei R; Armuzzi A; Fedeli P; Fedeli G; Gasbarrini G
Aliment Pharmacol Ther; 1998 Jun; 12(6):539-43. PubMed ID: 9678813
[TBL] [Abstract][Full Text] [Related]
66. Triple therapy as a cure for Helicobacter pylori infection.
Bardhan KD
Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S27-30. PubMed ID: 8930577
[TBL] [Abstract][Full Text] [Related]
67. Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole.
Gisbert JP; Gisbert JL; Marcos S; Grávalos RG; Carpio D; Pajares JM
Aliment Pharmacol Ther; 1999 Oct; 13(10):1311-6. PubMed ID: 10540045
[TBL] [Abstract][Full Text] [Related]
68. Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer.
Catalano F; Catanzaro R; Bentivegna C; Brogna A; Condorelli G; Cipolla R
Aliment Pharmacol Ther; 1998 Jan; 12(1):59-62. PubMed ID: 9692702
[TBL] [Abstract][Full Text] [Related]
69. Omeprazole or ranitidine bismuth citrate triple therapy to treat Helicobacter pylori infection: a randomized, controlled trial in Vietnamese patients with duodenal ulcer.
Mao HV; Lak BV; Long T; Chung NQ; Thang DM; Hop TV; Chien NN; Hoan PQ; Henley KS; Perez-Perez GI; Connor BA; Stone CD; Chey WD
Aliment Pharmacol Ther; 2000 Jan; 14(1):97-101. PubMed ID: 10632652
[TBL] [Abstract][Full Text] [Related]
70. Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate.
Ricciardiello L; Cannizzaro O; D'Angelo A; Ederle A; Gerace G; Iaquinto G; Reina G; Scarpulla G; Spadaccini A; Olivieri A; Tosatto R; Fossi S; Pozzato P; Zagari M; Bazzoli F; Roda E
Aliment Pharmacol Ther; 1998 Jun; 12(6):533-7. PubMed ID: 9678812
[TBL] [Abstract][Full Text] [Related]
71. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
Tam YH; Yeung CK; Lee KH
Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605
[TBL] [Abstract][Full Text] [Related]
72. Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer.
Bardhan KD; Dallaire C; Eisold H; Duggan AE
Gut; 1997 Aug; 41(2):181-6. PubMed ID: 9301496
[TBL] [Abstract][Full Text] [Related]
73. Ranitidine bismuth citrate in the first-line of Helicobacter pylori treatment.
Cisarò F; Astegiano M; De Angelis C; Saracco G; Rizzetto M; Pellicano R
Panminerva Med; 2011 Jun; 53(2):138. PubMed ID: 21659979
[No Abstract] [Full Text] [Related]
74. The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication.
Akyildiz M; Akay S; Musoglu A; Tuncyurek M; Aydin A
Eur J Intern Med; 2009 Jan; 20(1):53-7. PubMed ID: 19237093
[TBL] [Abstract][Full Text] [Related]
75. Low- versus high-dose azithromycin triple therapy for Helicobacter pylori infection.
Chey WD; Fisher L; Barnett J; Delvalle J; Elta GH; Hasler WL; Nostrant T; Palaniappan J; Scheiman J
Aliment Pharmacol Ther; 1998 Dec; 12(12):1263-7. PubMed ID: 9882036
[TBL] [Abstract][Full Text] [Related]
76. Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection.
Tursi A; Brandimarte G; Giorgetti G; Modeo ME; Gigliobianco A
Hepatogastroenterology; 2002; 49(46):1006-9. PubMed ID: 12143188
[TBL] [Abstract][Full Text] [Related]
77. Helicobacter pylori infection.
Suerbaum S; Michetti P
N Engl J Med; 2002 Oct; 347(15):1175-86. PubMed ID: 12374879
[No Abstract] [Full Text] [Related]
78. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
[TBL] [Abstract][Full Text] [Related]
79. Duodenal ulcer healing rates in a one-year follow-up study with ranitidine bismuth citrate and antibiotics.
Wurzer H; Bardhan KD; Marcelino M; Jahnsen J; Allmaier M
Hepatogastroenterology; 2001; 48(42):1641-7. PubMed ID: 11813591
[TBL] [Abstract][Full Text] [Related]
80. Therapeutic efficacy of ranitidine bismuth citrate with clarithromycin for seven days in the eradication of Helicobacter pylori in Brazilian peptic ulcer patients.
Eisig JN; Silva FM; Hashimoto C; Chehter EZ; Laudanna AA
Sao Paulo Med J; 2003 Jan; 121(1):15-8. PubMed ID: 12751338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
